Copyright
©The Author(s) 2016.
World J Gastrointest Endosc. Jan 10, 2016; 8(1): 4-12
Published online Jan 10, 2016. doi: 10.4253/wjge.v8.i1.4
Published online Jan 10, 2016. doi: 10.4253/wjge.v8.i1.4
Prep | Advantages | Disadvantages |
4 L PEG | Effective | Poor taste |
Safe in most populations | Very high volumes | |
Poorly tolerated by patients | ||
2 L PEG | Effective | Poor taste |
Safe in most populations | High volumes | |
High cost | ||
MiraLAX | Well tolerated by patients | Not as effective as prescription PEG preparations |
Available over the counter | Rare reports of hyponatremia | |
Existing studies indicate it is safe | ||
Sodium phosphate | Available as oral tab | Inappropriate for use in patients with renal disease, volume depletion, heart or liver failure, or who are taking ACEi or NSAIDs |
Well tolerated by patients | Risk of acute phosphate nephropathy and subsequent chronic kidney disease | |
Sodium picosulfate | Cost | |
Well tolerated by patients | Not as effective as PEG or OSS | |
OSS | Small volumes to be ingested | Inappropriate for patients with heart failure, renal insufficiency, end stage liver disease, or baseline electrolyte abnormalities |
Pleasant taste | High cost | |
Well tolerated by patients | High cost | |
Highly effective | Not as well studied | |
Available as oral tab |
- Citation: Harrison NM, Hjelkrem MC. Bowel cleansing before colonoscopy: Balancing efficacy, safety, cost and patient tolerance. World J Gastrointest Endosc 2016; 8(1): 4-12
- URL: https://www.wjgnet.com/1948-5190/full/v8/i1/4.htm
- DOI: https://dx.doi.org/10.4253/wjge.v8.i1.4